UNITEDHEALTH GROUP INC (UNH)

UnitedHealth Group has seen its analyst fair value estimate move from $424.23 to $475.23, a shift of about 12% in the underlying price target framework. Recent research attributes this change to Q2 earnings, updates around Medicare Advantage and Optum Health, and refreshed 2026 earnings models.

After a thorough review of the ... steady earnings growth within a year or so. Since that time the company has executed even better than we expected. "Mr. Market" is beginning to recognize what we saw a year ago and UnitedHealth Group's discounted shares are beginning to recover." ... UnitedHealth G…

UnitedHealth Group's Q2 2026 results show improved margins, a lower medical cost ratio, and raised earnings guidance, signaling its turnaround from 2025's steep stock decline is gaining traction.

UnitedHealth (NYSE:UNH) Earnings Spark Fresh Value Debate

UnitedHealth Group has delivered a strong 68.6% return over the past year, yet its valuation checks point to a more mixed picture rather than a clear bargain or an obviously stretched stock. Over the last 12 months, the stock is up 68.6%, which puts recent buyers in a comfortable position and ...